Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
Excessive glutamatergic signalling within the basal ganglia is implicated in the progression of Parkinson’s disease (PD) and inthe emergence of dyskinesia associated with long-term treatment with L-DOPA. There is considerable research focus on the discovery and development of compounds that modulate...
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
Wiley
2013-01-01
|
| Series: | Parkinson's Disease |
| Acceso en liña: | http://dx.doi.org/10.1155/2013/196028 |